Dr. Wuthrick specializes in radiation therapy for skin cancers such as melanoma, Merkel cell carcinoma, squamous cell carcinoma, and basal cell carcinoma. Dr. Wuthrick is interested in the combination of high dose per fraction radiation therapy and immunotherapy in melanoma and Merkel cell carcinoma. He is involved in numerous early phase clinical trials exploring the role of MAPK pathway inhibitors with radiation therapy. Dr. Wuthrick has a leadership role in the NCI-sponsored cooperative groups NRG, Alliance for Oncology, and SWOG, which conduct large practice-changing clinical trials in cutaneous and gastrointestinal cancers.
View More